Dietary consumption of EPS derived from Lactobacillus delbrueckii, EPS-R1, sensitized Colon26 and 4T1 tumors to anti-CTLA4 blockade therapy, significantly reducing tumor progression [59]. The gene discussed is CTLA4; the disease is neoplasm.